By Michael Erman NEW YORK, Feb 19 (Reuters) - Online telehealth company Hims & Hers Health, seeking growth drivers as its ...

Feb 19 (Reuters) - Hims & Hers Health said on Thursday it will acquire Australian digital health company Eucalyptus in a deal ...

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.

Hims & Hers caused a firestorm last week when it revealed that it planned to launch a knockoff version of Novo Nordisk's new ...

Hims & Hers Health, Inc. faces volatile earnings as compounded GLP-1 setbacks pressure shares. Click for this HIMS stock ...

Hims & Hers’ stock surges as a $1.2 billion deal to buy an Australia-based telehealth company affirms the health-and-wellness company’s global ambitions.

Consumer health and wellness platform Hims & Hers will ramp up its international presence with the acquisition of Australian ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital ...

Novo Nordisk A/S said it’s suing Hims & Hers Health Inc. for making knock-offs of its obesity medicines, even as Hims ...

Hims & Hers is buying the Australian telehealth firm Eucalyptus as it looks to make inroads in more countries globally.

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...